0 CHECKOUT

Summary: Irvine Unified School District Community Facilities District No. 86-1, California Irvine Unified School District Community Facilities District No. 09-1; Special Assessments Jun 11

  • ID: 1824637
  • June 2011
  • Region: California
  • Standard & Poors

Abstract
Standard & Poor's Ratings Services assigned its 'BBB+' rating to Irvine Unified School District Community Facilities District (CFD) no. 09-1, Calif.'s series 2011 subordinate taxable Qualified School Construction Bonds (QSCB) special tax revenue bonds issued on behalf of Irvine Unified School District CFD No. 86-1. At the same time, Standard & Poor's affirmed its 'A' rating on CFD No. 86-1's outstanding senior series 2009 bonds. The outlook on all ratings is stable. The ratings reflect our view of the districts': Residential and commercial demographics in a high-income area of northern Orange County, with access to the Los Angeles area employment base; Good, 1.76x maximum annual debt service (MADS) coverage of senior and subordinate debt; Large and stable special tax base,...

Companies mentioned in this report are: Irvine Unif Sch Dist Comnty Facs Dist #86-1,Irvine Unif Sch Dist Comnty Facs Dist #09-1
Action: Affirmed
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress READ MORE >

Note: Product cover images may vary from those shown

Irvine Unif Sch Dist Comnty Facs Dist #86-1,Irvine Unif Sch Dist Comnty Facs Dist #09-1

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.